SUNNYVALE, Calif.--(BUSINESS WIRE)--Silk Road Medical, Inc., a company dedicated to preventing the devastating burden of stroke through surgical innovation, today announced key events at the upcoming Society for Vascular Surgery 2018 Vascular Annual Meeting (VAM) June 20-23 at the Hynes Convention Center in Boston. These include real-world data presentations comparing the company’s TransCarotid Artery Revascularization (TCAR) procedure to transfemoral carotid artery stenting (TFCAS) and carotid endarterectomy (CEA), as well as other company-sponsored events about TCAR.
Two podium presentations will feature data from the Society for Vascular Surgery’s TCAR Surveillance Project, launched in 2016 to obtain real-world comparative outcomes of TCAR and other carotid artery treatments from centers participating in the Vascular Quality Initiative (VQI):
- “In-hospital Outcomes of TransCarotid Artery Revascularization (TCAR) and Carotid Endarterectomy (CEA) in the SVS Vascular Quality Initiative” (VESS05) will be presented by Dr. Marc Schermerhorn of Beth Israel Deaconess Medical Center (Boston) on Wednesday, June 20 at 8:30 a.m. in Room 311.
- “TransCarotid Artery Revascularization (TCAR) vs. Transfemoral Carotid Artery Stenting (TFCAS) in the SVS Vascular Quality Initiative” (SS24) will be presented by Dr. Mahmoud Malas of Johns Hopkins Hospital (Baltimore) on Friday, June 22 at 4:22 p.m. in Ballroom A/B.
Read More: https://www.businesswire.com/news/home/20180618005276/en/Silk-Road-Medical-Announces-Key-Events-Society
Silk Road Medical Announces Key Events for Society for Vascular Surgery 2018 Vascular Annual Meeting
Via: Business Wire